Early amelioration of insulin resistance and reduction of interleukin-6 in Werner syndrome using pioglitazone

J Am Geriatr Soc. 2008 Jan;56(1):173-4. doi: 10.1111/j.1532-5415.2007.01484.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Biomarkers / blood
  • Follow-Up Studies
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance*
  • Interleukin-6 / blood*
  • Male
  • Middle Aged
  • Pioglitazone
  • Receptor, Insulin / drug effects
  • Thiazolidinediones / therapeutic use*
  • Werner Syndrome / blood
  • Werner Syndrome / drug therapy*

Substances

  • Biomarkers
  • Hypoglycemic Agents
  • Interleukin-6
  • Thiazolidinediones
  • Receptor, Insulin
  • Pioglitazone